文献速递皮肤感染

美国蜂窝织炎住院后30天再入院分析

Analysis of Readmissions Following Hospitalization for Cellulitis in the United States.
PubMed 文献 · JAMA Dermatol · 2019-01-01

年龄和保险状态与再入院率升高相关。

要点

  • 蜂窝织炎出院后30天全因非计划再入院率为9.8%。
  • 再入院最常见诊断仍为皮肤和皮下组织感染。

核心结论

  • 蜂窝织炎住院后再入院常见且费用高昂,可能通过改进诊断、治疗和出院协调来预防。

研究设计与样本

  • 回顾性队列分析,使用2014年美国全国再入院数据库,纳入447 080例(95%CI 429 927-464 233)以蜂窝织炎为主要诊断的成人住院索引病例。

主要发现

  • 总体30天全因非计划再入院率为9.8%(95%CI 9.6%-10.0%)。
  • 再入院最常见诊断为皮肤和皮下组织感染。

临床怎么用

  • 临床应关注蜂窝织炎出院后的再入院风险,尤其针对保险状态相关差异。
  • 改进诊断、治疗和出院协调可能降低再入院率及费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cellulitis commonly results in hospitalization. Limited data on the proportion of cellulitis admissions associated with readmission are available. OBJECTIVE: To characterize the US national readmission rate associated with hospitalization for treatment of cellulitis. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort analysis of cellulitis admissions from the nationally representative 2014 Nationwide Readmissions Database calculated readmission rates for all cellulitis admissions and subsets of admissions. The multicenter population-based cohort included adult patients admitted for conditions other than obstetrical or newborn care. Data were collected from January 1 through November 30, 2014, and analyzed from February 1 through September 18, 2018. Bivariate logistic regression models were used to assess differences in readmission rates by patient characteristics. Costs were calculated for all readmissions after discharge from hospitalization for cellulitis (hereinafter referred to as cellulitis discharge) and by readmission diagnosis. EXPOSURES: Admission with a primary diagnosis of cellulitis. MAIN OUTCOMES AND MEASURES: Proportion of cellulitis admissions associated with nonelective readmission within 30 days, characteristics of patients readmitted after cellulitis discharge, and costs associated with cellulitis readmission. RESULTS: A total of 447 080 (95% CI, 429 927-464 233) index admissions with a primary diagnosis of cellulitis (53.8% male [95% CI, 53.5%-54.2%]; mean [SD] age, 56.1 [18.9] years) were included. Overall 30-day all-cause nonelective readmission rate after cellulitis discharge was 9.8% (95% CI, 9.6%-10.0%). Among patients with cellulitis, age (odds ratio for 45-64 years, 0.78; 95% CI, 0.75-0.81; P = .001) and insurance status (odds ratio for Medicare, 2.45; 95% CI, 2.33-2.58; P < .001) were associated with increased readmission rates. The most common diagnosis of readmissions included skin and subcutaneous tissue infections. The total cost associated with nonelective readmissions attributed to skin and subcutaneous infections within 30 days of a cellulitis discharge during the study period was $114.4 million (95% CI, $106.8-$122.0 million). CONCLUSIONS AND RELEVANCE: Readmission after hospitalization for cellulitis is common and costly and may be preventable with improved diagnostics, therapeutics, and discharge care coordination.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Fisher JM, Feng JY, Tan SY, et al. Analysis of Readmissions Following Hospitalization for Cellulitis in the United States. JAMA Dermatol. 2019. PMID: 30810708. doi:10.1001/jamadermatol.2018.4650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。